Teva Pharmaceutical Industries LimitedTeva Pharmaceutical Industries LimitedTeva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪19.43 B‬USD
−0.84USD
‪−559.00 M‬USD
‪15.85 B‬USD
‪1.13 B‬
Beta (1Y)
0.53

About TEVA


CEO
Richard Francis
Headquarters
Tel Aviv
Founded
1901
FIGI
BBG000C0CD58
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
T
TEVA.GJ
Teva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026
Yield to maturity
8.75%
Maturity date
Feb 1, 2026
T
TFAC
TEVA P.FI.NL III 16/46
Yield to maturity
7.26%
Maturity date
Oct 1, 2046
T
US88163VAD1
TEVA PHARM.FIN. 2036
Yield to maturity
6.04%
Maturity date
Feb 1, 2036
T
TFAB
TEVA P.FI.NL III 16/26
Yield to maturity
5.81%
Maturity date
Oct 1, 2026

Explore more bonds